-
Mashup Score: 11On the Run: Gabriela Hobbs, MD | ASH Clinical News | American Society of Hematology - 2 month(s) ago
Linda Kossoff is a medical writer and editor based in Los Angeles, California. Dr. Hobbs is a hematologist/oncologist and assistant professor at Harvard Medical School. She also serves as the myeloproliferative neoplasms service director and clinical director of leukemia service at Massachusetts General Hospital. When and where did you develop an interest in running, and how did it evolve into marathon running in particular? I was part of a high school track-and-field group in Mexico City, where I grew
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 20Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib - 3 month(s) ago
Not available.
Source: haematologica.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1
Svetlana Mojsov led early studies of GLP-1, the hormone behind Wegovy, Ozempic and other blockbusters.
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 24Paper: TP53 mutations and Their Impact on Survival in Patients with Myeloproliferative Neoplasms - 5 month(s) ago
Program: Oral and Poster Abstracts Session: 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster II Hematology Disease Topics & Pathways: adult, MPN, genomics, Chronic Myeloid Malignancies, Diseases, Adverse Events, Myeloid Malignancies, Biological Processes, Study Population, Human 1 Division of Hematology, Department of Medicine, Brigham and Women’s Hospital/Harvard Medical School, Boston, MA 2 Department of Medicine, Mass General Brigham, Salem Hospital,
Source: ash.confex.comCategories: General Medicine News, Hem/OncsTweet-
Congrats Cilomar @Cilomarf and Benjamin @DrRolles on your abstract @ASH_hematology #ASH2023, thanks also to @MaxStahlMD & all the co-authors @DanaFarber @BrighamHeme, check out abstract here: https://t.co/Q0l89N1L80 @TheBoettcherLab, appreciate all your insights on #TP53! #MPNsm https://t.co/fObYq9wQZa
-
-
Mashup Score: 3Paper: Mutations in the RNA Splicing Factors U2AF1 and SRSF2 are Context-Dependent in Myeloproliferative Neoplasms - 6 month(s) ago
Program: Oral and Poster Abstracts Session: 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster I Hematology Disease Topics & Pathways: Fundamental Science, Research, MPN, Chronic Myeloid Malignancies, Diseases, Myeloid Malignancies 1 Department of Medicine, Division of Hematology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 2 Division of Hematology, Department of Medicine, Brigham and Women’s Hospital, Boston, MA 3 Department of Medical
Source: ash.confex.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 23Paper: TP53 mutations and Their Impact on Survival in Patients with Myeloproliferative Neoplasms - 6 month(s) ago
Program: Oral and Poster Abstracts Session: 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster II Hematology Disease Topics & Pathways: adult, MPN, genomics, Chronic Myeloid Malignancies, Diseases, Adverse Events, Myeloid Malignancies, Biological Processes, Study Population, Human 1 Division of Hematology, Department of Medicine, Brigham and Women’s Hospital/Harvard Medical School, Boston, MA 2 Department of Medicine, Mass General Brigham, Salem Hospital,
Source: ash.confex.comCategories: General Medicine News, Hem/OncsTweet-
Congrats Cilomar @Cilomarf and Benjamin @DrRolles on your abstract @ASH_hematology #ASH2023, thanks also to @MaxStahlMD & all the co-authors @DanaFarber @BrighamHeme, check out abstract here: https://t.co/Q0l89N1L80 @TheBoettcherLab, appreciate all your insights on #TP53! #MPNsm https://t.co/fObYq9wQZa
-
-
Mashup Score: 7Paper: Unlike TET2 and ASXL1, Co-Occurring DNMT3A Mutations Are Not Associated with Increased Age in JAK2-Mutant Myeloproliferative Neoplasms (MPNs) - 6 month(s) ago
Program: Oral and Poster Abstracts Session: 631. Myeloproliferative Syndromes and Chro nic Myeloid Leukemia: Basic and Translational: Poster III Joan How, MD 1, Anna E. Marneth, PhD 1,2, Baransel Kamaz, MD 3 *, Chulwoo J. Kim 4 *, Donna S. Neuberg, ScD 5, Siyang Ren, MS 5 *, Mohammed Wazir 6, Lachelle D. Weeks, MD, PhD 7, Maximilian Stahl, MD 8, Daniel J. DeAngelo 9, R. Coleman Lindsley 10, Marlise R. Luskin, MD 7, Sahand Hormoz, PhD 11 * and Ann Mullally, MD 1 1 Division of Hematology, Department of
Source: ash.confex.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 23Paper: TP53 mutations and Their Impact on Survival in Patients with Myeloproliferative Neoplasms - 6 month(s) ago
Program: Oral and Poster Abstracts Session: 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster II Hematology Disease Topics & Pathways: adult, MPN, genomics, Chronic Myeloid Malignancies, Diseases, Adverse Events, Myeloid Malignancies, Biological Processes, Study Population, Human 1 Division of Hematology, Department of Medicine, Brigham and Women’s Hospital/Harvard Medical School, Boston, MA 2 Department of Medicine, Mass General Brigham, Salem Hospital,
Source: ash.confex.comCategories: General Medicine News, Hem/OncsTweet-
Congrats Cilomar @Cilomarf and Benjamin @DrRolles on your abstract @ASH_hematology #ASH2023, thanks also to @MaxStahlMD & all the co-authors @DanaFarber @BrighamHeme, check out abstract here: https://t.co/Q0l89N1L80 @TheBoettcherLab, appreciate all your insights on #TP53! #MPNsm https://t.co/fObYq9wQZa
-
-
Mashup Score: 5Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib - 7 month(s) ago
Not available.
Source: haematologica.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Research Developments Advancing Involving CALR-Mutated MPNs - 8 month(s) ago
Researchers sought to identify research advances in the development of possible treatments for CALR-mutated MPNs.
Source: www.hematologyadvisor.comCategories: Hem/Oncs, Latest HeadlinesTweet
Congrats @GabyHobbs, loved this, very inspiring! https://t.co/LyCBR7ULTV @ASHClinicalNews @ASH_hematology https://t.co/chqnb3026C